Lyme disease - Part II: Clinical features and treatment

Cutis

Volumn 69, Issue 6, 2002, Pages 443-448

  Montiel, Norma J ^a   Baumgarten, Jana M ^a   Sinha, Animesh A ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BORRELIA BURGDORFERI; CHILD; HUMAN; ISOLATION AND PURIFICATION; LYME DISEASE; MICROBIOLOGY; REVIEW;

ADULT; BORRELIA BURGDORFERI; CHILD; HUMANS; LYME DISEASE;

EID: 0036598357     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Malane MS, Grant-Kels JM, Feder HM Jr, et al. Diagnosis of Lyme disease based on dermatologic manifestations. Ann Intern Med. 1991;115:490-498.
2. Rahn DW, Felz MW. Lyme disease update. Current approach to early, disseminated, and late disease. Postgrad Med. 1998;103:51-64.
3. Sigal L. Pitfalls in the diagnosis and management of Lyme disease. Arthritis Rheum. 1998;41:195-204.
4. Habif TP. A Color Guide to Diagnosis and Therapy: Clinical Dermatology. 3rd ed. St. Louis, Mo: Mosby; 1996.
5. Hu LT, Klempner MS. Update on the prevention, diagnosis, and treatment of Lyme disease. Adv Intern Med. 2001;46:247-275.
6. Shapiro ED, Gerber MA. Lyme disease. Clin Infect Dis. 2000;31:533-542.
7. Steere AC. Diagnosis and treatment of Lyme arthritis. Med Clin North Am. 1997;81:179-194.
8. Hercogova J, Brzonova I. Lyme disease in central Europe. Curr Opin Infect Dis. 2000;14:133-137.
9. Lever WF, Schaumburg-Lever G. Histopathology of the Skin. 7th ed. Philadelphia, Pa: Lippincott; 1990.
10. Aberer E, Neumann R, Stanck G. Is localised scleroderma a Borrelia infection. Lancet. 1985;2:278.
11. Ozkan S, Atavey N, Fetil E, et al. Evidence of Borrelia burgdorferi in morphea and lichen sclerosus. Int J Dermatol. 2000;39:278-283.
12. Schempp C, Bocklage H, Lange R, et al. Further evidence for Borrelia burgdorferi infection in morphea and lichen sclerosus et atrophicus confirmed by DNA amplification. J Invest Dermatol. 1993;100:717-720.
13. Fujiwara H, Fujiwara K, Hashimoto K, et al. Detection of Borrelia burgdorferi DNA (B garinii or B afzelii) in morphea and lichen sclerosus et atrophicus tissues of German and Japanese but not of US patients. Arch Dermatol. 1997;133:41-44.
14. Weide B, Schittec B, Klyscz T, et al. Morphoea is neither associated with features of Borrelia burgdorferi infection, nor is this agent detectable in lesional skin by polymerase chain reaction. Br J Dermatol. 2000;143:780-785.
15. Recommendations for the use of Lyme disease vaccine. Recommendations of the Advisory Committee on Immunization Practices (AClP). MMWR Recomm Rep. 1999;48(RR07):1-17,21-25.
16. Fitzpatrick T, Eisen A, Wolff K, et al. Dermatology in General Medicine. 4th ed. New York, NY: McGraw-Hill; 1993.
17. Centers for Disease Control and Prevention. Lyme disease - United States, 1996. MMWR Morb Mortal Wkly Rep. 1997;46:531-535.
18. Terkeltaub RA. Lyme disease 2000. Emerging zoonoses complicate patient work-up and treatment. Geriatrics. 2000;55:34-44.
19. Loewen PS, Marra CA, Marra F. Systemic review of the treatment of early Lyme disease. Drugs. 1999;57:157-173.
20. Committee on Infectious Diseases. Prevention of Lyme disease. Pediatrics. 2000;105:142-147.
21. Edlow JA. Lyme disease and related tick-borne illnesses. Ann Emerg Med. 1999;33:680-693.
22. Klempner MS, Hu LT, Evans J, et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med. 2001;345:85-92. Available at: http://www.nejm.org. Accessed June 12, 2001.
23. Centers for Disease Control and Prevention. Lyme disease - United States, 1999. MMWR Morb Mortal Wkly Rep. 2001;50:181-185.
24. Nadelman RB, Nowakowski J, Fish D, et al. Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. N Engl J Med. 2001;345:79-84. Available at: http://www.nejm.org. Accessed June 12, 2001.
25. Evans J. Lyme disease. Curr Opin Rheumatol. 2000;12:311-317.
26. Thanassi WT, Schoen RT. The Lyme disease vaccine: conception, development, and implementation. Ann Intern Med. 2000;132:661-668.
27. Rahn DW, Evans J. Lyme Disease. Philadelphia, Pa: The American College of Physicians; 1998.
28. Steere AC, Sikand VK, Parenti DL, et al. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group. N Engl J Med. 1998;339:216-222.